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Abstract
Background: Clostridium difficile is the most common known cause of antibiotic-associated diarrhea. Upon the
disturbance of gut microbiota by antibiotics, C. difficile establishes growth and releases toxins A and B, which cause
tissue damage in the host. The symptoms of C. difficile infection disease range from mild diarrhea to pseudomembranous
colitis and toxic megacolon. Interestingly, 10–50 % of infants are asymptomatic carriers of C. difficile. This longitudinal
study of the C. difficile colonization in an infant revealed the dynamics of C. difficile presence in gut microbiota.
Methods: Fifty fecal samples, collected weekly between 5.5 and 17 months of age from a female infant who was an
asymptomatic carrier of C. difficile, were analyzed by 16S rRNA gene sequencing.
Results: Colonization switching between toxigenic and non-toxigenic C. difficile strains as well as more than 100,000-fold
fluctuations of C. difficile counts were observed. C. difficile toxins were detected during the testing period in some infant
stool samples, but the infant never had diarrhea. Although fecal microbiota was stable during breast feeding, a dramatic
and permanent change of microbiota composition was observed within 5 days of the transition from human milk to cow
milk. A rapid decline and eventual disappearance of C. difficile coincided with weaning at 12.5 months. An increase in the
relative abundance of Bacteroides spp., Blautia spp., Parabacteroides spp., Coprococcus spp., Ruminococcus spp., and
Oscillospira spp. and a decrease of Bifidobacterium spp., Lactobacillus spp., Escherichia spp., and Clostridium spp. were
observed during weaning. The change in microbiome composition was accompanied by a gradual increase of fecal pH
from 5.5 to 7.
Conclusions: The bacterial groups that are less abundant in early infancy, and that increase in relative abundance after
weaning, likely are responsible for the expulsion of C. difficile.
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Background
Clostridium difficile (C. difficile), a gram-positive spore-
forming anaerobic bacterium, accounts for half a million
cases of diarrhea [1] and 14,000 deaths [2] annually in
the USA. The symptoms of C. difficile disease in adults
range from mild diarrhea to pseudomembranous colitis
and toxic megacolon. Up to 50 % of infants are asymp-
tomatic carriers of C. difficile [3–5]. The percentage of
infants colonized is higher at the beginning of life, an
average of 37 % at 1 month of age [6], and declines to
30 % between 1 and 6 months of age. At the end of the
first year, the colonization rate drops to 10 % [6]. The
cause of this decrease in colonization is unknown, and
most studies have reported data through these events as
an aggregate of many individuals, unlinked to specific
events in each participant during that timeframe. C. dif-
ficile disease results from tissue damage caused by two
toxins, A (TcdA) and B (TcdB), which are produced by
toxigenic C. difficile strains. Surprisingly, toxin concen-
tration in asymptomatic infants can be similar to the
level in adults with pseudomembranous colitis [7].
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C. difficile infection (CDI) is associated with a disturb-
ance in gut microbiota. Antibiotic exposure is the most
important risk factor for CDI. The usage of broad-
spectrum antibiotics, such as clindamycin, aminopenicil-
lins, cephalosporins, and fluoroquinolones disturbs the
normal gut microbiota and predisposes persons to sub-
sequent CDI [8–10]. Restoration of the disturbed micro-
biota by bacteriotherapy is effective in treating recurrent
CDI [11].
The high C. difficile colonization rate in infants may
be contributed to the fact that the commensal micro-
biota in pre-weaned infants dominated by Bifidobacter-
ium spp. and Lactobacillus spp. [12] might be more
permissive to the colonization of C. difficile than adult
microbiota dominated by Bacteroidetes spp. and Firmi-
cutes spp. [13]. The gut microbiome structure can be
rapidly altered by changes in diet [14]. Thus, the notable
differences in diet likely contribute to the difference in the
microbiota composition of infant and adult gut. The most
significant change of diet in infancy is weaning. Weaning
is the process of introducing an infant to an adult diet and
withdrawing the supply of mother’s milk. In this study,
weaning refers to the transition from human milk to cow
milk with the same supplemental solid food intake. We
observed in this study that weaning was associated with
the maturation of infantile gut microbiota to adult-like gut
microbiota.
The aim of this study was to evaluate C. difficile
colonization in an infant pre- and post-weaning. Solid
food was introduced at the age of 4 months with the con-
tinued feeding of human milk before stool collection began.
The major change in the infant’s diet was the cessation of
breast milk and introduction to cow milk at a single day
around the age of 12 months. Fecal samples were collected
from an infant weekly from 5.5 months of age to 17 months
of age. The infant was an asymptomatic carrier at the be-
ginning of the study and transitioned to C. difficile negative
during the testing period. The composition of infant fecal
microbiota was analyzed retrospectively to investigate the
cause of the disappearance of C. difficile. We hypothesize
that breast milk promotes infant-like gut microbiota which
allows the colonization of C. difficile.
Methods
Infant and sample collection
A female infant was identified as an asymptomatic carrier
of C. difficile at age 5.5 month using a combination of im-
munoassay detection of glutamate dehydrogenase (GDH)
and bacterial culture. The infant stool sample was tested
positive for GDH on C. DIFF QUIK CHEK COMPLETE®
(TechLab, Inc, Blacksburg, VA), and C. difficile colonies
were isolated from infant stool samples using ethanol-
shock spore enrichment method [15]. The infant was de-
livered through Cesarean delivery and fed exclusively with
breast milk until the age of 4 months when solid food was
gradually introduced. Solid food included oatmeal, fruits,
yogurt, and protein such as tofu, eggs, and meat. The com-
position of solid food remained constant throughout the
duration of sample collection. An average of 20 oz. of hu-
man milk or cow milk was consumed daily throughout
this study. Formula was never given to the infant. Fecal
samples were collected weekly for 50 weeks starting on 1
Nov. 2013 when the infant was 5.5 months of age. Samples
were collected at home and stored at 2–8 °C overnight be-
fore they were aliquoted and stored frozen at −20 °C until
analyzed. The study was approved by the TechLab Institu-
tional Review Board and included informed consent ob-
tained from the mother.
Measurement of pH of fecal samples
Fecal samples stored at −20 °C were thawed, brought to
room temperature, and homogenized. The pH of fecal sam-
ples was measured by placing Micro Combination pH Elec-
trode (Thermo Scientific, Waltham, MA) directly into the
center of the homogenized samples at room temperature.
C. difficile isolation and ribotyping
C. difficile isolation was done using ethanol-shock spore
enrichment method [15]. Tenfold serial dilutions were
made before plating on to cycloserine-cefoxitin-fructose
agar (CCFA) plates for spore count. Isolated colonies were
used to inoculate prereduced, anaerobically sterilized brain
heart infusion broth (Anaerobe Systems, Morgan Hill, CA)
and the inoculated media was incubated at 37 °C for
72 hours anaerobically. Genomic DNA was isolated from
C. difficile colonies and PCR ribotype was determined using
the procedure developed by Stubbs et al. [16].
C. difficile antigen and toxin quantification
The amount of GDH, quantified to nanogram over gram
on an ELISA (C. DIFF CHEK® - 60, TechLab, Inc,
Blacksburg, VA) using a standard curve generated with
recombinant GDH, was used to indicate the presence of
metabolically active vegetative C. difficile in fecal samples.
The presence or absence of toxin A and B was determined
by C. DIFF QUIK CHEK COMPLETE® (TechLab, Inc,
Blacksburg, VA). Toxin B in the fecal samples was con-
firmed by the TOX-B TEST (TechLab, Inc, Blacksburg,
VA). Toxin B-specific cytotoxicity was confirmed by the
neutralization of fecal samples using toxin B-specific
antibodies on human foreskin cells (Diagnostic Hybrids,
Athens, OH). Briefly, fecal supernatant fluids were pre-
pared from specimens diluted 1:10 and clarified by centri-
fugation and filtration. The cytotoxicity neutralization with
specific antitoxin was recorded 48 h post-inoculation.
Fecal samples that tested positive on the TOX-B TEST
were diluted tenfold and re-tested for further titration.
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Sample preparation for 16S rRNA gene analysis
Genomic DNA was isolated from 50 stool samples with
PowerSoil DNA Isolation Kit (MoBio), following the manu-
facturer’s instructions. The V4 region of 16S rRNA gene
was amplified with forward primer 515F and GoLay bar-
coded 806R reverse primers [17]. Duplicate PCRs were set
up using different reverse primers to verify the reproduci-
bility of the amplification. The resulting 100 amplicons
were purified with QIAquick PCR Purification Kit (Qiagen,
Hilden, Germany) and pooled and sequenced by paired-
end of 150 cycles on a MiSeq sequencer (Illumina, San
Diego, CA, USA). The average results of the two technical
duplicates were used in the subsequent analyses.
Taxonomy assignments and community structure analyses
The sequencing results were processed using Quantitative
Insights Into Microbial Ecology (QIIME) [18]. The bi-
directional reads were joined using QIIME’s default join_
paired_ends script. The merged reads were filtered based
on Phred quality score ≥20, which corresponds to sequen-
cing error rate ≤0.01. Chimeras were identified using
USEARCH61 [19] and removed from downstream ana-
lysis. After the removal of chimeras, the remaining se-
quences were mapped into operational taxonomic units
(OTUs) against the Greengenes reference sequences (ver-
sion 2013.5) with the program UCLUST [19]. Microbial
taxonomy was assigned using a naïve Bayesian classifier
trained with the Greengenes 2013.5 reference sequences
[20, 21]. The level of species was classified by running
BLAST [22] against the Greengenes data set. OTUs which
showed significant change in relative abundance was iden-
tified using QIIME’s “group_significance.py” script with
Kruskal-Wallis test. Principle coordinates were calculated
using unweighted UniFrac metrics [23]. QIIME com-
mands used to generate the principal coordinate plots
were included in Additional file 1.
Results
Fluctuation of C. difficile colony count and ribotype
switch in a colonized infant
The transition from human milk to cow milk paralleled
with rapid disappearance of C. difficile in this study. The
infant was initially culture positive for C. difficile and
remained positive for a period of 292 days. GDH, a meta-
bolic enzyme produced by vegetative C. difficile, was quan-
tified and used as a marker to indicate the active growth of
vegetative C. difficile. Among the samples that were cul-
ture positive for C. difficile, a variation of GDH level be-
tween less than 1 ng to over 9000 ng GDH per gram of
feces was observed (Fig. 1a). The number of C. difficile
spores in feces was also performed on a subset of the sam-
ples to check the bacterial load. The lowest spore count
for C. difficile positive stools was 4.0 × 103/g in samples
collected on days 216 and 258 of the testing period. The
highest spore count was 7 × 108/g in the samples collected
on day 6 and 68. Based on spore counts, we observed a
more than 100,000-fold decrease in C. difficile load be-
tween day 68 and days 80 and 216. Note that although
the amount of GDH reflects the amount of vegetative
cells present in samples, the amount of GDH does not
strictly correlate with the spore count of C. difficile
from the same fecal sample. No detectable amount of
GDH was present in samples collected on and after day
278 to the end of the testing period, confirming along
with the absence of cultivable C. difficile, the disappear-
ance of C. difficile.
Eleven out of 50 stool samples were positive for C. diffi-
cile cytotoxicity over a 191-day period. In Fig. 1a, samples
that tested positive for toxins are indicated with solid black
bars, whereas samples that were negative for toxins are
represented with open bars. Toxigenic C. difficile was first
detected on day 68. A switching between toxin negative
samples and toxin positive samples was observed through-
out 2/3 of the testing period. Interestingly, based on toxin
titration in cytotoxicity assays, samples collected on days
68, 74, and 96 contained 10 times higher amounts of toxin
than amounts shown to cause severe CDI in adults, yet the
infant remained asymptomatic.
Ribotyping was performed periodically to identify the
ribotypes of the C. difficile isolated from a subset of stool
samples (Fig. 1a). For the first 60 days of the testing period,
non-toxigenic ribotype 010 was present. In the sample
collected on day 68, the first toxin positive sample in the
series, both non-toxigenic ribotype 010 and toxigenic ribo-
type 014/020 were detected. Ribotype 014/020 was also
identified in toxin positive samples collected on days 88,
188, 258, and 271. The sample collected on day 271 con-
tained no detectable amount of toxin by cytotoxicity assay
and showed a low GDH level. Although 014/020 has been
reported to be the most commonly identified ribotype of
C. difficile isolated from diarrheic pediatric CDI cases [24],
all stool samples containing 014/020 in this study were
solid and the infant remained asymptomatic.
Rapid change in microbiota composition at phylum level
after weaning
Diet greatly influence gut microbiome [14] by providing
various substrates that promote the growth of different
groups of bacteria. At the beginning of the study, the infant
was 5.5 months of age with solid food already introduced.
The pH of the fecal samples was tested. Breastfed infants
produce stool with pH around 5, which was also observed
at the beginning of this study (Fig. 2). The fecal pH grad-
ually increased to 7 toward the end of the sample collection.
Coincide with the increase of pH of infant fecal samples, a
gradual increase of microbial diversity represented by Shan-
non diversity index [18] was observed throughout this study
(Additional file 2: Figure S1).
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To investigate the exclusion of C. difficile from the
colonized infant, microbial structure was analyzed by
16S rRNA gene sequencing of the total microbial
community. Taxonomy assignments and community
structure analyses were done as described [25]. In Fig. 1b,
the structure of the fecal microbiota is displayed and
A B
Fig. 1 The dynamics of C. difficile colonization and microbiome composition in infant samples. a The amount of GDH quantified by ELISA was
used to indicate the relative abundance of C. difficile in infant fecal samples. Samples that tested positive for C. difficile toxins are indicated by
black bars while samples that tested negative for toxins are indicated by open bars. C. difficile spore ribotype and spore count are presented for a
subset of samples. The switch from mother’s milk to cow milk was indicated with the purple arrowed lines. Sample collection started on day 1
when the infant was 5.5 months old. b The microbiome composition of infant fecal samples are profiled at the phylum level. The microbiota
samples are grouped by hierarchical clustering based on UniFrac distances. Samples collected before weaning and samples collected after
weaning formed two distinct clusters
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color-coded by the various bacterial phyla that were
present. A striking decrease of Actinobacteria was ob-
served between samples collected on days 224 and 230.
The record of diet revealed the complete termination of
human milk feeding on day 225. Further analysis of the
ratio of dominant bacterial phyla indicated that within
5 days from the cessation of human milk and its replace-
ment by cow milk, the Bacteroidetes to Firmicutes ratio
increased dramatically while the Actinobacteria to Firmi-
cutes ratio decreased slightly (Fig. 3). These changes in
the microbiome structure were sustained for 134 days
till the end of the testing period. The Bacteroidetes to
Firmicutes ratio started to increase on days 216 and 224,
just before the cessation of human milk. On these days,
small amounts (approximately 4 oz) of cow milk were
given to the infant in addition to human milk. Whether
addition of cow milk initiated these changes in the micro-
biome remains to be determined.
The rapid change in microbial structure that occurred
within 5 days of weaning was also indicated in a principal
coordinate analysis based on unweighted UniFrac metrics
(Fig. 4). Microbial community structures were distributed
into two distinct clusters that represent pre-weaning and
post-weaning fecal samples. Data representing days 224
and 230 were both in the positions connecting the two
communities of data points, indicating that a major transi-
tion of microbial structure occurred simultaneously with
weaning.
Microbial structure change at genus and species level
coincided with weaning
A second comparison of microbiota composition, with data
gathered into pre-weaning (days 1–224) and post-weaning
(days 225–363) groups, was done using a parametric t test
(p values <0.005). At the genus level, the relative abun-
dance of Bacteroides spp., Blautia spp., Parabacteroides
spp., Coprococcus spp., Ruminococcus spp., and Oscillospira
spp. dramatically increased post-weaning while the rela-
tive abundance of Bifidobacterium spp., Lactobacillus
spp., Escherichia spp., and Clostridium spp. decreased
(Fig. 5). The phylogenetic designation of the genera which
changed significantly during weaning are summarized in
Additional file 3: Table S1.
In addition, 69 operational taxonomic units (OTUs)
showed significant change in relative abundance pre- and
post- weaning (FDR p value ≤0.01). The majority of these
OTUs were assigned to species that have not been isolated
in culture. Among the cultivable species, Bifidobacterium
Fig. 2 Gradual pH increase in infant fecal samples. The pH of infant
fecal samples collected weekly from 5.5 months of age (day 1) to
17 months of age (day 363) were tested. Weaning occurred on day
224. The samples collected before weaning are represented by blue
squares while samples collected after weaning are represented by red
squares. A gradual pH increase was observed throughout the test period
Fig. 3 Weaning changes the ratio of bacteria phyla in the infant gut. When the infant was weaned off breast milk to cow milk, the Bacteroidetes
to Firmicutes ratio increased dramatically and the Actinobacteria to Firmicutes ratio decreased slightly. Weaning happened between sample points
day 224 and 230
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adolescentis, Bifidobacterium bifidum, Escherichia coli,
and Lactobacillus zeae were more abundant before wean-
ing, whereas Bacteroides caccae, Bacteroides uniformis,
Corynebacterium durum, Ruminococcus callidus, Rumino-
coccus gnavus, and Ruminococcus torques were more
abundant after weaning (Table 1).
Discussion
The primary goal of this study was to investigate the dy-
namics of C. difficile colonization in an infant before
and after the transition from human milk to cow milk.
The high rate of asymptomatic carriage of C. difficile in
infants is well documented but until now the transition
from carrier state to non-carrier state has not been char-
acterized. We conducted a longitudinal study on an
infant to investigate the transition from C. difficile
colonization to a C. difficile-negative state. When sample
collection of this study started the infant was colonized
with 7.0 × 107 CFU/g of C. difficile spores per gram of
feces at 5.5 months of age. When the study ended, the
infant was 17 months old and was free of C. difficile. As
high as 7.1 × 108 CFU/g of toxigenic C. difficile was de-
tected in a sample collected on day 68. This bacterial
load was high enough to cause CDI in adults [26] but
did not cause diarrhea in this infant. The amount of
GDH, which is produced by vegetative C. difficile, was
quantified on an ELISA as an indicator of vegetative
growth. Close to 10,000 ng/g feces of GDH was detected
in the stool collected on experiment day 88. Less than
20 ng/g feces of GDH concentration was detected in the
last 10 samples (days 278 to 363), confirming the dimin-
ished growth of C. difficile. This is the first study to use
the combination of GDH concentration and spore count
to investigate the dynamics of both vegetative and spore
forms of C. difficile, respectively, in a colonized infant.
The presence of GDH was shown to be both a sensitive
and specific biomarker of C. difficile [27]. The high spore
count of C. difficile in the infant stool makes infants res-
ervoirs of C. difficile.
Ribotype switches between non-toxigenic and toxi-
genic C. difficile were captured in this longitudinal study.
At the beginning of the testing period, the infant was
colonized with non-toxigenic C. difficile ribotype 010.
On day 68, a mixture of non-toxigenic ribotype 010 and
toxigenic ribotype 014/020 coexisted. On day 88, only
toxigenic ribotype 014/020 was isolated (Fig. 1a). The ac-
quisition of two different strains of C. difficile indicates
that C. difficile can be acquired from the environment,
and the colonization with different strains of C. difficile
represented transient events. Although the C. difficile
spore counts and GDH amounts varied, colonization
with C. difficile was sustained throughout the human
milk-fed stage from day 1 to 224.
Samples collected on days 68, 74, 88, and 96 contained
10 times the amount of C. difficile toxin that can cause
C. difficile disease in adults, yet the infant remained
asymptomatic on these days. This is consistent with the
report from Viscidi et al. that the concentrations of
toxins in the stool of healthy infants can reach the levels
of toxins that cause severe disease in adults [7]. This
study is one of the first to document the extreme tem-
poral variability of both vegetative cells and spores that
can be present in an asymptomatic infant. The ineffect-
iveness of toxins on infants was hypothesized to be due
to the lack of receptor on infant gut epithelial cells [28]
but such receptor has not been identified.
A second goal of this study was to document the de-
tailed longitudinal changes in gut microbiota during the
first year and a half of life of an infant. The maturation
of infant microbiota is thought to be a gradual process
until reaching the composition of adult microbiota at
the age of 3 years [29]. However, in this unique case of
an infant experiencing abrupt termination of human
milk feeding and transition to cow milk feeding, the in-
fant microbiota shifted from Bifidobacterium spp. and
Lactobacillus spp. dominated microbiota to Bacteroi-
detes spp. and Firmicutes spp. dominated microbiota
within 5 days. It appears that cessation of breastfeeding
rather than introduction of solid foods caused the shift
from Bifidobacterium spp. and Lactobacillus spp. domi-
nated microbiota to Bacteroidetes spp. and Firmicutes
Fig. 4 The structure of microbial communities is distinct before and
after weaning. Principal coordinate analysis based on unweighted
UniFrac metrics indicates that microbiota community structures are
distinct between pre-weaning (blue dots) and post-weaning (red squares)
fecal samples. Weaning happened between experiment days 224 and
230. On experiment day 292 when the infant produced two loose stools,
significant alteration of the microbiota composition was observed
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spp. dominated microbiota, as solid foods had been in-
troduced 6 weeks before the start of the study and con-
tinued to be part of the infant’s diet. This agrees with
the results of Backhed et al. [12]. There are significant
differences between human milk and cow milk. Human
milk contains less than half the protein, about 50 %
more lactose [30] and a significantly higher amount of
oligosaccharides [31, 32]. The oligosaccharides in human
milk are resistant to digestion in the small intestines and
promote the growth of Bifidobacteria once they reach
the colon [33, 34]. The differences in composition of
human milk and cow milk produce environments
that favor different groups of bacteria pre- and post-
weaning. The timing of microbiota maturation may
then be more dependent on the timing of weaning
than is currently recognized. For example, the sud-
den decrease of oligosaccharides after the cessation
of human milk feeding may explain the rapid
decrease of Bifidobacteria after weaning observed in
this study.
The disappearance of C. difficile after weaning also
coincided with the shift from Bifidobacterium spp. and
Lactobacillus spp. dominated microbiota to Bacteroi-
detes spp. and Firmicutes spp. dominated microbiota. C.
difficile does not carry the genes to synthesize hydrolytic
enzymes capable of cleaving monosaccharides from
oligosaccharide side chains [35] and must depend upon
acquisition of sugars from other members of the colonic
microbiome. Bifidobacterium bifidum, which is abun-
dant in infant microbiota, is capable of degrading mucin
O-glycans [36]. Free sialic acid, the mucin degradation
product made by Bifidobacterium bifidum, serves as an
energy source of C. difficile [37]. Infantile gut microbiota
likely accommodate C. difficile by producing metabolic
substrates such as free sialic acid. A significant decrease
of Bifidobacterium bifidum was observed after weaning
Fig. 5 Genera of bacteria which changed significantly before and after weaning. The comparison of microbiota composition pre- and
post-weaning was done using parametric t test (p values <0.005). The relative abundance of bacteria genera was calculated as percentage
of the total bacteria detected. The relative abundance of Bifidobacterium spp., Lactobacillus spp., Escherichia spp., and Clostridium spp.
decreased post-weaning while the relative abundance of Bacteroides spp., Blautia spp., Parabacteroides spp., Coprococcus spp., Ruminococcus spp., and
Oscillospira spp. increased
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in this study. The relative abundance of C. difficile posi-
tively correlated with the relative abundance of OTUs
162 and 267 representing C. bifidum with coefficients
0.37 and 0.29 and p values 0.007 and 0.04, respectively.
The decreased relative abundance of free sialic acid-
producing bacterial species restricts the energy source of
C. difficile and may contribute to the disappearance of
C. difficile.
In addition, adult gut microbiota form a barrier against
C. difficile colonization by competing for metabolic sub-
strates and producing inhibitors against C. difficile [38]. For
example, an inverse association between C. difficile and the
relative abundance of members of the Bacteroidetes phylum
and of other Clostridium spp. in human intestines has been
observed [39]. Bacteroides spp. have been shown to form a
resistance barrier against C. difficile by competing for
monomeric sugars such as glucose, N-acetylglucosamine,
succinate, and sialic acids [35, 40–43]. The percentage of
Bacteroides spp. increased from 0.02 to 48 % in the gut
microbiota from the first sample to the last sample in our
study. In particular, Bacteroides caccae and Bacteroides uni-
formis were more abundant post-weaning. The increase of
Bacteroides spp. after weaning limited the carbon source of
C. difficile and therefore contributed to the disappearance
of C. difficile.
The barrier against C. difficile colonization in Bacteroi-
detes spp. and Firmicutes spp. dominated microbiota
also results from metabolic products produced by the
adult-like microbiota that inhibit the germination and
growth of C. difficile. For example, bile acids strongly in-
fluence the germination of C. difficile spores and the
growth of vegetative C. difficile cells. Primary bile acids
stimulate C. difficile spore germination [44] whereas sec-
ondary bile acids inhibit the growth of vegetative C. diffi-
cile [45, 46]. Importantly, the dynamic balance of bile
acid composition in the colon is influenced by the com-
mensal bacterial species in the gut. Primary bile acids are
deconjugated by bacteria, such as Clostridium scindens,
and further modified into secondary bile acids which are
inhibitory to C. difficile in the colon [47]. Ruminococcus
gnavus, one of the cultivable bacteria species identified in
this study that increased in relative abundance after wean-
ing, converts lithocholate to ursodeoxycholate and plays a
major role in ursodeoxycholate formation in the colon
[48]. Ursodeoxycholate inhibits C. difficile spore germin-
ation [45]. The increased level of R. gnavus after weaning
may further contribute to the disappearance of C. difficile
by increasing the concentration of ursodeoxycholate in
the colon.
Previous studies have indicated that Ruminococcus cal-
lidus is part of the resistance barrier against C. difficile.
R. callidus was found to be more abundant in healthy
people than in Crohn’s disease patients, who are also at
higher risk of CDI [49, 50]. R. callidus is associated with
the gut mucosa and is restored after fecal transplants
[51]. In our study, the increased relative abundance of R.
callidus after weaning may contribute to the disappear-
ance of C. difficile.
Whether children under the age of 2 should be tested
and/or treated for CDI is debatable. Rates of positive C. dif-
ficile tests were the same among children with or without
diarrhea [52]. More than 20 % of children with diarrhea
who tested positive for C. difficile also tested positive for
other pathogens, making it difficult to determine whether
C. difficile was the true cause of diarrhea or part of the
commensal microbiota [53]. Even when children under
2 years of age were diagnosed with CDI, the outcomes of











5 1.55 × 10−7 Increase
Bacteroides
uniformis
3 1.08 × 10−4 Increase
205 1.07 × 10−5
326 2.91 × 10−5
Corynebacterium
durum
109 1.43 × 10−3 Increase
Ruminococcus
callidus
65 7.13 × 10−3 Increase
Ruminococcus
gnavus
6 5.09 × 10−5 Increase
217 3.50 × 10−5
249 2.30 × 10−6
322 2.83 × 10−3
Ruminococcus
torques
28 4.96 × 10−7 Increase
Bifidobacterium
adolescentis
128 3.57 × 10−5 Decrease
180 2.39 × 10−3
233 2.05 × 10−3
329 5.23 × 10−7
Bifidobacterium
bifidum
162 6.61 × 10−4 Decrease
267 2.55 × 10−4
Escherichia coli 1 3.50 × 10−5 Decrease
121 3.06 × 10−3
131 1.73 × 10−3
144 1.83 × 10−4
189 7.93 × 10−3
223 2.47 × 10−3
243 7.41 × 10−4
Lactobacillus
zeae
4 2.66 × 10−3 Decrease
169 3.21 × 10−3
247 2.83 × 10−3
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treated and untreated CDI were not significantly different
[54]. The guidelines published by the National Health Ser-
vices (NHS) in Britain suggested that children under the
age of 2 not be tested for CDI [55]. In this study, the toxin
was not detectable by cytotoxicity assay in the sample col-
lected on day 271, but C. difficile 014/020 could be grown
on CCFA plates and its DNA ribotyped. Thus, although
present, the 014/020 C. difficile was not producing toxin.
These results demonstrate once again that even when toxi-
genic C. difficile can be detected by molecular means, it
may not be causing disease. Molecular assays targeting
genes encoding the C. difficile toxins will, in such cases,
produce false positive results. Whether toxigenic C. difficile
causes disease or not appears to depend on the age-related
susceptibility of children and the composition of the gut
microbiota. Better understanding of the colonization of C.
difficile in children will lead to accurate diagnosis and
proper treatment of CDI in children.
Conclusions
This longitudinal study of C. difficile colonization in an in-
fant revealed up to 105-fold fluctuation of C. difficile
count, colonization with both non-toxigenic and toxigenic
C. difficile strains, as well as rapid shift from Bifidobacter-
ium spp. and Lactobacillus spp. dominated microbiota to
Bacteroidetes spp. and Firmicutes spp. dominated micro-
biota within 5 days of weaning from human milk. The dis-
appearance of C. difficile after weaning likely is due to a
resistance barrier formed by the adult-like microbiota.
Bacteria species identified in this study that are more
abundant in adult-like post-weaning microbiota may be
components of the resistant barrier against CDI.
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